FEATURED NEWS

MATEC
May 11, 2017
FDA Updates STRIBILD and TYBOST labels May 4, 2017 The STRIBILD and TYBOST labels were updated to include revised text regarding corticosteroids as follows: STRIBILD Section 7 Drug Interaction, Table 6 was revised for systemic, inhaled, nasal, and opthalmic corticosteroids as follows. Table 6 Established and Other Potentially Significant Drug MORE
MATEC
April 7, 2017
Adult and Adolescent Opportunistic Infections Guidelines Updated U.S. Department of Health and Human Services, April 7, 2017: The Malaria section of the Guidelines for the Prevention and Treatment of Opportunistic Infections in HIV-Infected Adults and Adolescents was recently updated. In this revision, the epidemiology and treatment sections were updated MORE
MATEC
March 24, 2017
Updates to the Guidelines for the Prevention and Treatment of Opportunistic Infections in HIV-Infected Adults and Adolescents The Guidelines for the Prevention and Treatment of Opportunistic Infections in HIV Infected Adults and Adolescents document was published in an electronic format that could be easily updated as relevant changes in prevention and MORE
MATEC
July 14, 2016
New CDC MMWR report on antibiotic-resistant gonorrhea includes concerning findings for azithromycin - one of two drugs in the only recommended treatment regimen Centers for Disease Control and Prevention (CDC), July 14, 2016. On July 14, 2016 CDC, On July 14, 2016, the Centers for Disease Control and Prevention (CDC) MMWR report titled Neisseria MORE
FDA
March 24, 2016
Update: Meningococcal Vaccine Recommendations March 18th, Chicago Department of Public Health. The Chicago Department of Public Health (CDPH) is investigating a new case of invasive meningococcal disease (IMD) caused by Neisseria meningitidis serogroup C reported in March 2016, 9 months following the last case tied to a Chicago-area outbreak of serogroup MORE